979 related articles for article (PubMed ID: 28615077)
21. "They don't like us….": Barriers to antiretroviral and opioid substitution therapy among homeless HIV positive people who inject drugs in Delhi: A mixed method study.
Kumar S; Gupte HA; Isaakidis P; Mishra JK; Munjattu JF
PLoS One; 2018; 13(8):e0203262. PubMed ID: 30161255
[TBL] [Abstract][Full Text] [Related]
22. Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.
MacArthur GJ; van Velzen E; Palmateer N; Kimber J; Pharris A; Hope V; Taylor A; Roy K; Aspinall E; Goldberg D; Rhodes T; Hedrich D; Salminen M; Hickman M; Hutchinson SJ
Int J Drug Policy; 2014 Jan; 25(1):34-52. PubMed ID: 23973009
[TBL] [Abstract][Full Text] [Related]
23. Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries.
Petersen Z; Myers B; van Hout MC; Plüddemann A; Parry C
Harm Reduct J; 2013 Aug; 10():13. PubMed ID: 23957896
[TBL] [Abstract][Full Text] [Related]
24. "Take services to the people": strategies to optimize uptake of PrEP and harm reduction services among people who inject drugs in Uganda.
Kamusiime B; Beima-Sofie K; Chhun N; Nalumansi A; Nalukwago GK; Kasiita V; Twesige CC; Kansiime R; Muwonge TR; Kyambadde P; Kadama H; Mudiope P; Glick S; Lambdin B; Mujugira A; Heffron R
Addict Sci Clin Pract; 2024 Feb; 19(1):13. PubMed ID: 38395940
[TBL] [Abstract][Full Text] [Related]
25. Modelling the impact and cost-effectiveness of non-governmental organizations on HIV and HCV transmission among people who inject drugs in Ukraine.
Stone J; Trickey A; Walker JG; Bivegete S; Semchuk N; Sazonova Y; Varetska O; Altice FL; Saliuk T; Vickerman P
J Int AIDS Soc; 2023 Apr; 26(4):e26073. PubMed ID: 37012669
[TBL] [Abstract][Full Text] [Related]
26. Reviewing harm reduction for people who inject drugs in Asia: the necessity for growth.
Stone KA
Harm Reduct J; 2015 Oct; 12():32. PubMed ID: 26472335
[TBL] [Abstract][Full Text] [Related]
27. HIV and hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: Findings from respondent-driven sampling surveys.
Handanagic S; Bozicevic I; Civljak M; Dominkovic Z; Sevic S; Barbaric J; Nemeth Blazic T; Dakovic Rode O; Begovac J
Int J Drug Policy; 2016 Jun; 32():57-63. PubMed ID: 27160504
[TBL] [Abstract][Full Text] [Related]
28. HIV prevention cascades for injection and sexual risk behaviors among HIV-negative people who inject drug in Iran.
Gangi MF; Karamouzian M; Nedjat S; Rahimi-Movaghar A; Yazdani K; Shokoohi M; Mirzazadeh A
Int J Drug Policy; 2020 Oct; 84():102868. PubMed ID: 32717706
[TBL] [Abstract][Full Text] [Related]
29. Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trial.
Solomon SS; Quinn TC; Solomon S; McFall AM; Srikrishnan AK; Verma V; Kumar MS; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Thomas DL; Sachdeva KS; Lucas GM; Mehta SH
J Hepatol; 2020 Jan; 72(1):67-74. PubMed ID: 31604081
[TBL] [Abstract][Full Text] [Related]
30. Patterns of HIV testing, drug use, and sexual behaviors in people who use drugs: findings from a community-based outreach program in Phnom Penh, Cambodia.
Mburu G; Ngin C; Tuot S; Chhoun P; Pal K; Yi S
Addict Sci Clin Pract; 2017 Dec; 12(1):27. PubMed ID: 29202872
[TBL] [Abstract][Full Text] [Related]
31. Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services.
Bartholomew TS; Plesons M; Serota DP; Alonso E; Metsch LR; Feaster DJ; Ucha J; Suarez E; Forrest DW; Chueng TA; Ciraldo K; Brooks J; Smith JD; Barocas JA; Tookes HE
Addict Sci Clin Pract; 2024 Mar; 19(1):21. PubMed ID: 38528570
[TBL] [Abstract][Full Text] [Related]
32. Pharmacy-randomized intervention delivering HIV prevention services during the syringe sale to people who inject drugs in New York City.
Lewis CF; Rivera AV; Crawford ND; DeCuir J; Amesty S
Drug Alcohol Depend; 2015 Aug; 153():72-7. PubMed ID: 26118831
[TBL] [Abstract][Full Text] [Related]
33. Reality and feasibility for pharmacy-delivered services for people who inject drugs in Xichang, China: Comparisons between pharmacy staff and people who inject drugs.
Yang Y; Latkin C; Luan R; Yang C
Int J Drug Policy; 2016 Jan; 27():113-20. PubMed ID: 26123897
[TBL] [Abstract][Full Text] [Related]
34. Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.
Dutta A; Wirtz AL; Baral S; Beyrer C; Cleghorn FR
Curr Opin HIV AIDS; 2012 Jul; 7(4):362-8. PubMed ID: 22647588
[TBL] [Abstract][Full Text] [Related]
35. How far will they go? Assessing the travel distance of current and former drug users to access harm reduction services.
Allen S; Ruiz M; O'Rourke A
Harm Reduct J; 2015 Mar; 12():3. PubMed ID: 25889589
[TBL] [Abstract][Full Text] [Related]
36. What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries.
Degenhardt L; Mathers BM; Wirtz AL; Wolfe D; Kamarulzaman A; Carrieri MP; Strathdee SA; Malinowska-Sempruch K; Kazatchkine M; Beyrer C
Int J Drug Policy; 2014 Jan; 25(1):53-60. PubMed ID: 24113623
[TBL] [Abstract][Full Text] [Related]
37. Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas - United States, 2013.
Des Jarlais DC; Nugent A; Solberg A; Feelemyer J; Mermin J; Holtzman D
MMWR Morb Mortal Wkly Rep; 2015 Dec; 64(48):1337-41. PubMed ID: 26655918
[TBL] [Abstract][Full Text] [Related]
38. The Potential Reach of Opioid Substitution Settings to Deliver HCV Care to People Who Inject Drugs in Australia.
Butler K; Day C; Dietze P; Bruno R; Alati R; Burns L
J Subst Abuse Treat; 2015 Nov; 58():90-4. PubMed ID: 26117080
[TBL] [Abstract][Full Text] [Related]
39. Using a programmatic mapping approach to plan for HIV prevention and harm reduction interventions for people who inject drugs in three South African cities.
Scheibe A; Shelly S; Lambert A; Schneider A; Basson R; Medeiros N; Padayachee K; Savva H; Hausler H
Harm Reduct J; 2017 Jun; 14(1):35. PubMed ID: 28592246
[TBL] [Abstract][Full Text] [Related]
40. Barriers and facilitators of HIV and hepatitis C care among people who inject drugs in Nairobi, Kenya: a qualitative study with peer educators.
Ludwig-Barron NT; Guthrie BL; Mbogo L; Bukusi D; Sinkele W; Gitau E; Farquhar C; Monroe-Wise A
Harm Reduct J; 2021 Dec; 18(1):133. PubMed ID: 34922548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
